
Opko Health, Inc.: updates and filings
Price
$1.61
November 19, 2026Market cap $1.2B
What Ploutos Investor adds for Opko Health
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Jan 28, 2027
A rough estimate from when it has reported before, which has varied. The company announces the date itself.
November 2026
July 2026
April 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Oct 15, 2026Material agreement enteredForm8-K
- Oct 2, 2026Other material eventsForm8-K
- Aug 28, 2026Quarterly report (amendment)for the period to Jun 30, 2026Form10-Q/A
- Aug 28, 2026Quarterly report (amendment)for the period to Mar 31, 2026Form10-Q/A
- Aug 14, 2026Material agreement entered, new material financial obligationForm8-K
- Aug 7, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- Jul 27, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 27, 2026Results of operationsForm8-K
- Jul 1, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jun 18, 2026Shareholder voteForm8-K
- May 15, 2026Additional annual meeting materialFormDEFA14A
- Apr 30, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 30, 2026Additional annual meeting materialFormDEFA14A
- Apr 30, 2026Annual meeting proxy statementFormDEF 14A
- Apr 28, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 28, 2026Results of operationsForm8-K
- Mar 19, 2026Officer or director changeForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 26, 2026Results of operationsForm8-K
- Oct 29, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Oct 29, 2025Results of operationsForm8-K
- Oct 1, 2025Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Oct 15, 2026 | 8-K | Material agreement entered | Document |
| Oct 2, 2026 | 8-K | Other material events | Document |
| Aug 28, 2026 | 10-Q/A | Quarterly report (amendment)for the period to Jun 30, 2026 | Document |
| Aug 28, 2026 | 10-Q/A | Quarterly report (amendment)for the period to Mar 31, 2026 | Document |
| Aug 14, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Aug 7, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| Jul 27, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 27, 2026 | 8-K | Results of operations | Document |
| Jul 1, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jun 18, 2026 | 8-K | Shareholder vote | Document |
| May 15, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 30, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 30, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 28, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 28, 2026 | 8-K | Results of operations | Document |
| Mar 19, 2026 | 8-K | Officer or director change | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 26, 2026 | 8-K | Results of operations | Document |
| Oct 29, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Oct 29, 2025 | 8-K | Results of operations | Document |
| Oct 1, 2025 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since May 13, 1996: every report, 8-K, meeting and letter. Of its other filings (892 in all), the newest.
The full analysis
What do Opko Health's filings show?
The filings are where every one of Opko Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.